Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
6.38
-0.37 (-5.48%)
Jun 25, 2025, 1:31 PM - Market open

Actuate Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
Market Capitalization
125155--
Enterprise Value
118142--
Last Close Price
6.757.96--
Quick Ratio
0.430.980.434.71
Current Ratio
0.461.050.434.71
Return on Equity (ROE)
---442.40%-
Return on Assets (ROA)
-413.44%-255.41%-132.96%-
Return on Capital (ROIC)
---279.06%-
Buyback Yield / Dilution
-766.91%-483.48%-18.54%-
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q